摘要
吉米沙星是氟喹诺酮类新药,能增加拓扑异构酶的亲合力;对大多数革兰氏阳性细菌有抗菌活性,对革兰氏阴性细菌也有抗菌活性;临床用于病原体所致的各种感染治疗。吉米沙星的抗菌谱广,抗菌作用强大,毒副反应少,有可能成为临床上广泛应用于治疗各种感染性疾病的常用药物。
出处
《中国药业》
CAS
2001年第12期54-55,共2页
China Pharmaceuticals
参考文献25
-
1Morrissey I, Clark S, Mathias I. The bactericidal activity of gemifloxacin(SB - 265805) [J]. J Med Microbiol, 2000 Sep 49(9): 841 - 844.
-
2Bush K, Macielag M. New approaches in the treatment of bacterial infections[J]. Curr Opin Chem Biol, 2000, Aug 4(4): 433 - 439.
-
3Allen A, Bygate E, Oliver S, et al. Pharmacokinetics and tolerability of gemifloxacin(SB-265805) after administration of single oral doses to healthy volunteers[J]. Antimicrob Agents Chemother, 2000, Jun, 44(6):1604-1608.
-
4Davy M, Bird N, Rost KL, et al. Lack of effect of gemifloxacin on the steady-state pharmacodynamics of warfarin in healthy volunteers [J].Chemotherapy, 1999 Nov - Dec 45 (6) : 491 - 495.
-
5Allen A, Bygate E, Faessel H, et al. The effect of ferrous sulphate and sucralfate on the bioavailability of oral gemifloxacin in healthy volunteers[J]. Int J Antimicrob Agents, 2000 Aug, 15 (4): 283 - 289.
-
6Morrissey I, George JT. Purification of pneumococcal type Ⅱ topoisomerases and inhibition by gemifloxacin and other quinolones[J]. J Antimicrob chemother, 2000, Apr, 45 (Suppl 1 ): 101 - 106.
-
7Ednie LM, JacobsMR, Appelbaum PC. Activity of gemifloxacin, a new broad- spectrum quinolone, against 200 pneumococci by four different susceptibility testing methods[J]. J Antimicrob Chemother, 2000, Apr,45 (4): 525 - 528.
-
8Fuentes F, Gimenez MJ, Marco F, et al. In vitro susceptibility to gemifloxacin and trovafloxacin of Streptococcus pneumoniae strains exhibiting decreased susceptibility to ciprofloxacin[J] . Eur J Clin Microbiol Infect Dis, 2000, Feb, 19(2): 137 - 139.
-
9Jones R N, Erwin M E. Development of gemifloxacin in vitro srsceptibility test methods for gonococci including quality control guidelines[J].Diagn Microbiol Infect Dis, 2000, Jul, 37 (3): 195 - 201.
-
10Jones R N, Deshpande L M, Erwin M E ,et al. Anti-gonococcal activity of gemifloxacin against fluoroquinolone- resestant strains and a comparison of agar dilution and Etest methods [J]. J Antimicrob Chemother, 2000, Apr, 45(Suppl 1 ): 67 - 70.
同被引文献21
-
1谢红刚,封宇飞,邹忠梅.新一代广谱氟喹诺酮类抗菌药吉米沙星[J].中国新药杂志,2005,14(3):353-355. 被引量:9
-
2王秀云,刘明亮.吉米沙星的安全性评价[J].国外医药(抗生素分册),2005,26(6):252-258. 被引量:6
-
3张宇.喹诺酮类抗茵药的研究进展[J].中国新药杂志,2006,15(16):1344-1350. 被引量:8
-
4燕成岭,樊淑珍,曹银芳,李凤娥.泌尿系感染的病原菌分布及耐药性分析[J].中华医院感染学杂志,2007,17(2):224-226. 被引量:35
-
5王海燕.尿路感染[M].肾脏病学.北京:人民卫生出版社,2008,1269.
-
6Waner-Lanbert drops clinaflozacin[J].Scrip,2000,28:2503-2505.
-
7First filing for Smith Kline Beecham's gemifloxacin[J].Scrip,1999,(2499):19.
-
8Zhanel GG,Ennis K,Vercaigne L,et al.A critical review of the fluoroquinolones:focus on respiratory infections[J].Drugs,2002,62(1):13-15.
-
9汪复.氟喹诺酮类药物临床应用进展[J].中华内科杂志,1999,38(1):65-67. 被引量:86
-
10谢翠刁,唐细兰.氟喹诺酮类抗菌药物[J].广东药学,1999,9(1):10-11. 被引量:3
二级引证文献22
-
1徐光凤,郑文武.喹诺酮类抗生素的研究进展与临床应用[J].中国基层医药,2006,13(9):1571-1572. 被引量:2
-
2李永法,杨勇.第四代喹诺酮类抗菌药物的临床应用[J].社区医学杂志,2007,5(01S):53-55. 被引量:4
-
3孙运凤.喹诺酮类抗菌药物的作用特点及合理应用[J].社区医学杂志,2007,5(03X):29-32. 被引量:6
-
4韩森,朱小梅.喹诺酮类药物诺氟沙星的热稳定性研究[J].中国新药杂志,2007,16(14):1104-1107. 被引量:16
-
5李然,王睿.新一代广谱氟喹诺酮类抗菌药物吉米沙星[J].中国抗生素杂志,2008,33(8):453-460. 被引量:17
-
6薛泳.2005—2007年某医院喹诺酮类抗菌药物利用分析[J].职业与健康,2008,24(19):2089-2091.
-
7王刚斌,程军.2006~2008年我院氟喹诺酮类抗菌药物应用分析[J].中国医院用药评价与分析,2009,9(5):354-357. 被引量:20
-
8黄昕明,王德才.7位取代杂环氟喹诺酮类药物构效关系研究概况[J].中国医院药学杂志,2009,29(14):1212-1215.
-
9潘明飞,王俊平,王硕,刘丽,郭睿莉.食品中氟喹诺酮类药物残留色谱检测方法的研究[J].食品与机械,2009,25(5):129-132. 被引量:4
-
10汝国庆.奎诺酮类抗生素类药物[J].中国中医药咨讯,2010(8):268-269. 被引量:1
-
1戚焕贞,郝建华.常见革兰氏阳性菌的耐药机制探讨[J].山东医药,2003,43(20):42-42. 被引量:3
-
2卢建东,王广宇.林可霉素致肌无力1例[J].海军医学杂志,2003,24(4):376-376. 被引量:1
-
3郝勇,胡聪.咪康唑增强华法令的抗凝血作用[J].解放军医药杂志,1997,19(5):398-399.
-
4耿雪睛.林可霉素过敏反应1例[J].实用临床医药杂志,1997,6(4):305-305.
-
5刘瑞丽,崔振吉.乳酸左氧氟沙星致过敏性休克1例[J].护理实践与研究,2005,2(5):63-63.
-
6赵丽平,岳红霞,袁进国.氧氟沙星甘露醇注射液与夫西地酸钠存在配伍禁忌[J].护理研究(中旬版),2007,21(6):1587-1587. 被引量:7
-
7曹西.抗生素为何不灵了[J].健康生活,1996,0(10):24-24.
-
8余红岚,莫非,张斌慧,王功娣,石凤兰.临床分离343株细菌的分布及耐药性分析[J].山东医药,2009,49(32):50-51. 被引量:4
-
9胡艳霞.注射用夫西地酸钠与盐酸氨溴索葡萄糖注射液存在配伍禁忌[J].全科护理,2012,10(25):2392-2392.
-
10汤枝鹏,朱天骄,顾谦群,李德海.Roquefortine类生物碱的研究进展[J].中国海洋药物,2013,32(2):76-84.